MétaCan
Menu
Back to cohort
Record W2107116316 · doi:10.1159/000314708

The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium Treatment

2010· article· en· W2107116316 on OpenAlexafffund
Thomas G. Schulze, Martin Alda, Mazda Adli, Nirmala Akula, Raffaella Ardau, Elise T. Bui, Caterina Chillotti, Sven Cichon, Piotr M. Czerski, Maria Del Zompo, Sevilla D. Detera‐Wadleigh, Paul Grof, Oliver Gruber, Ryota Hashimoto, Joanna Hauser, Rebecca Hoban, Nakao Iwata, Layla Kassem, Tadafumi Kato, Sarah Kittel‐Schneider, Sebastian Kliwicki, John R. Kelsoe, Ichiro Kusumi, Gonzalo Laje, Susan G. Leckband, Mirko Manchia, Glenda MacQueen, Takuya Masui, Norio Ozaki, Roy H. Perlis, Andrea Pfennig, Paola Piccardi, Guy A. Rouleau, Andreas Reif, Janusz Rybakowski, Johanna Sasse, Johannes Schumacher, Giovanni Severino, Jordan W. Smoller, Alessio Squassina, Gustavo Turecki, L. Trevor Young, Takeo Yoshikawa, Michael Bauer, Francis J. McMahon

Bibliographic record

VenueNeuropsychobiology · 2010
Typearticle
Languageen
FieldMedicine
TopicBipolar Disorder and Treatment
Canadian institutionsUniversité de MontréalCentre Hospitalier Universitaire Sainte-JustineDalhousie UniversityUniversity of TorontoMcGill UniversityDouglas Mental Health University InstituteUniversity of CalgaryDouglas CollegeUniversity of British Columbia
FundersNational Institute of Mental HealthRegione Autonoma della SardegnaNational Alliance for Research on Schizophrenia and DepressionBundesministerium für Bildung und ForschungDeutsche ForschungsgemeinschaftCanadian Institutes of Health ResearchU.S. Department of Veterans Affairs
KeywordsLithium (medication)PsychologyGeneticsMedicinePsychiatryBiology

Abstract

fetched live from OpenAlex

For more than half a decade, lithium has been successfully used to treat bipolar disorder. Worldwide, it is considered the first-line mood stabilizer. Apart from its proven antimanic and prophylactic effects, considerable evidence also suggests an antisuicidal effect in affective disorders. Lithium is also effectively used to augment antidepressant drugs in the treatment of refractory major depressive episodes and prevent relapses in recurrent unipolar depression. In contrast to many psychiatric drugs, lithium has outlasted various pharmacotherapeutic 'fashions', and remains an indispensable element in contemporary psychopharmacology. Nevertheless, data from pharmacogenetic studies of lithium are comparatively sparse, and these studies are generally characterized by small sample sizes and varying definitions of response. Here, we present an international effort to elucidate the genetic underpinnings of lithium response in bipolar disorder. Following an initiative by the International Group for the Study of Lithium-Treated Patients (www.IGSLI.org) and the Unit on the Genetic Basis of Mood and Anxiety Disorders at the National Institute of Mental Health,lithium researchers from around the world have formed the Consortium on Lithium Genetics (www.ConLiGen.org) to establish the largest sample to date for genome-wide studies of lithium response in bipolar disorder, currently comprising more than 1,200 patients characterized for response to lithium treatment. A stringent phenotype definition of response is one of the hallmarks of this collaboration. ConLiGen invites all lithium researchers to join its efforts.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.352
Threshold uncertainty score0.365

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.329
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations161
Published2010
Admission routes2
Has abstractyes

Explore more

Same venueNeuropsychobiologySame topicBipolar Disorder and TreatmentFrench-language works237,207